Mixed-lineage kinase 3 regulates B-Raf through maintenance of the B-Raf/Raf-1 complex and inhibition by the NF2 tumor suppressor protein

被引:75
作者
Chadee, DN
Xu, DZ
Hung, G
Andalibi, A
Lim, DJ
Luo, ZJ
Gutmann, DH
Kyriakis, JM
机构
[1] Tufts Univ, New England Med Ctr, Mol Cardiol Res Inst, Boston, MA 02111 USA
[2] Tufts Univ, Sch Med, Dept Med, Boston, MA 02111 USA
[3] House Ear Res Inst, Los Angeles, CA 90057 USA
[4] Boston Univ, Sch Med, Sect Endocrinol Diabet & Nutr, Boston, MA 02118 USA
[5] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA
关键词
extracellular signal-regulated kinase; mitogen-activated protein kinase/merlin;
D O I
10.1073/pnas.0510651103
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The Ras -> Raf -> MEK1/2 -> extracellular signal-regulated kinase (ERK) mitogen-activated protein kinase (MAPK) pathway couples mitogenic signals to cell proliferation. B-Raf and Raf-1 function within an oligomer wherein they are regulated in part by mutual transactivation. The MAPK kinase kinase (MAP3K) mixed-lineage kinase 3 (MLK3) is required for mitogen activation of B-Raf and cell proliferation. Here we show that the kinase activity of MLK3 is not required for support of B-Raf activation. Instead, MLK3 is a component of the B-Raf/Raf-1 complex and is required for maintenance of the integrity of this complex. We show that the activation of ERK and the proliferation of human schwannoma cells bearing a loss-of-function mutation in the neurofibromatosis 2 (NF2) gene require MLK3. We find that merlin, the product of NF2, blunts the activation of both ERK and c-Jun N-terminal kinase (JNK). Finally, we demonstrate that merlin and MLK3 can interact in situ and that merlin can disrupt the interactions between B-Raf and Raf-1 or those between MLK3 and either B-Raf or Raf-1. Thus, MLK3 is part of a multiprotein complex and is required for ERK activation. The levels of this complex may be negatively regulated by merlin.
引用
收藏
页码:4463 / 4468
页数:6
相关论文
共 25 条
  • [21] Functional analysis of the relationship between the neurofibromatosis 2 tumor suppressor and its binding partner, hepatocyte growth factor-regulated tyrosine kinase substrate
    Sun, CX
    Haipek, C
    Scoles, DR
    Pulst, SM
    Giovannini, M
    Komada, M
    Gutmann, DH
    [J]. HUMAN MOLECULAR GENETICS, 2002, 11 (25) : 3167 - 3178
  • [22] Mechanism of activation of the RAF-ERK signaling pathway by oncogenic mutations of B-RAF
    Wan, PTC
    Garnett, MJ
    Roe, SM
    Lee, S
    Niculescu-Duvaz, D
    Good, VM
    Jones, CM
    Marshall, CJ
    Springer, CJ
    Barford, D
    Marais, R
    [J]. CELL, 2004, 116 (06) : 855 - 867
  • [23] Endothelial apoptosis in Braf-deficient mice
    Wojnowski, L
    Zimmer, AM
    Beck, TW
    Hahn, H
    Bernal, R
    Rapp, UR
    Zimmer, A
    [J]. NATURE GENETICS, 1997, 16 (03) : 293 - 297
  • [24] Overlapping and specific functions of Braf and Craf-1 proto-oncogenes during mouse embryogenesis
    Wojnowski, L
    Stancato, LF
    Larner, AC
    Rapp, UR
    Zimmer, A
    [J]. MECHANISMS OF DEVELOPMENT, 2000, 91 (1-2) : 97 - 104
  • [25] Activation of B-Raf kinase requires phosphorylation of the conserved residues Thr598 and Ser601
    Zhang, BH
    Guan, KL
    [J]. EMBO JOURNAL, 2000, 19 (20) : 5429 - 5439